Latest Insights on PGR

Check Your Bills: Beat the Market by Investing in Companies You Use August 30, 2019 by Anthony Planas American Investor Today, Investment Opportunities, Trading Strategies New investors looking for the next BIG opportunity will overlook these mundane companies. But their performance puts them well ahead of the broader market. Here’s what you need to know to build the base of your portfolio. (2-minute read)
Great Stuff 8-23-2019 Chinese Tariffs & Trump Tweets Whipsaw the Stock Market August 23, 2019 by Joseph Hargett Great Stuff Friday Four Play: Jerome Powell Says “As You Wish” … Almost Fans of The Princess Bride know that the biggest classic blunder is getting involved in a land war in Asia. The second is betting against a Sicilian when death is on the line. After the events of this morning, I think we really must […]
Great Stuff 7-25-2019 Tesla’s “Production Hell” and “Logistics Hell” Tanks Shares July 25, 2019 by Joseph Hargett Great Stuff “Living easy, living free. Season ticket on a one-way ride.” AC/DC ain’t got nothing on Tesla Inc. (Nasdaq: TSLA). After going through “production hell” and “logistics hell,” CEO Elon Musk is in his own personal hell this morning. Tesla posted a loss of $1.12 per share in the second quarter, missing even the most bearish […]
Great Stuff 7-18-2019 Netflix Battles the Strangest Things July 18, 2019 by Joseph Hargett Great Stuff Did you cancel your Netflix Inc. (Nasdaq: NFLX) subscription? I didn’t cancel my subscription. So, that makes two of us still here, probably. Unless you’re sharing my account. I have been getting a lot of weird suggested shows to watch recently. Hmmm… The world’s largest online streaming company reported its second-quarter results last night. While […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Loving this. Should have started a long time ago.”

- Jay

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

Share This